SUMMARY Sera obtained from 34 men with Chlamydia trachomatis positive non-gonococcal urethritis, 34 men with C trachomatis negative non-gonococcal urethritis, 42 women with acute salpingitis, 38 healthy women, and 34 healthy men were studied for the presence of specific serum C trachomatis IgA and IgG antibodies. Serological results were correlated with C trachomatis isolation in cell culture.
Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections bodies by enzyme linked immunosorbent assay (ELISA)," -13 radioimmunoassay,'4 and immunoperoxidase assay'5 has been described.
To date, little is known about the role of serum IgA antibodies in chlamydial and viral infections. With regard to viral infection, several studies'6-2' have suggested that specific IgA antibody may be an indicator of an active infection.
In order to verify the feasibility of determining C trachomatis specific IgA serum antibody as an additional test for patients with chlamydial infections, a single antigen enzyme linked immunosorbent assay was adapted for specific C trachomatis serum IgA and compared with an immunofluorescence test. Serum IgG detection by an immunofluorescence technique was also performed on the same sera. Serological results were correlated with C trachomatis isolation in cell culture.
Material and methods

STUDY POPULATION
Serum samples and urethral or cervical cultures for C trachomatis were obtained from patients included in a multicentre study of sexually transmitted diseases. These included 34 men (mean age 25-4 years) with C trachomatis positive non-gonococcal urethritis, 34 men (mean age 24-4 years) with C trachomatis negative non-gonococcal urethritis, and 42 women (mean age 28-3 years) with acute salpingitis. The clinical diagnosis of acute salpingitis was based on common criteria, which included lower abdominal pain, abnormal vaginal discharge, adnexal tenderness, erythrocyte sedimentation rate >15 mm in the first hour, and usually fever (>38-C).
Thirty eight healthy women (mean age 27-2 years) and 34 healthy men (mean age 26 years) were also studied. Cultures for C trachomatis were not obtained from these two population groups.
Ten sera from children negative by the immunofluorescence test for serum IgA to C trachomatis were used as negative controls in the ELISA test.
CHLAMYDIAL ANTIGEN AND ELISA PROCEDURE
The LLC-MK2 cell line derived from monkey kidney cells was used for growing C trachomatis. The cells (which are highly susceptible to C trachomatis) were grown in 75 cm3 tissue culture flasks with Eagle's minimum essential medium containing 10% fetal calf serum and 10 ,ug/ml gentamicin. When confluent monolayers had formed, the medium was replaced with the same medium containing 5 % fetal calf serum, 10,g/ml gentamicin, 1 ug/ml cycloheximide, and 30 ,uM glucose. LLC-MK2 cell monolayers were infected with C trachomatis serotype L2 (434-BU strain, provided by J Schachter, San Francisco, California). The infected cultures were incubated at 37°C for 48 h.
Elementary bodies of C trachomatis were purified by the method of Caldwell et al, 22 by Renografin gradients, with minor modifications. Briefly, infected cells were ruptured by sonication and centrifuged. The supernatant was layered over 8 ml of a 35% (vol/vol) Renografin (ER Squibb and Sons Inc, Princeton, New Jersey, USA) solution in 0-01 M HEPES and centrifuged at 43 000 g for 1 h at 4°C in a SW 27 rotor (Beckman Instruments Inc, Fullerton, California.) The pellet was resuspended in 0-01 M sodium phosphate (pH 7.2) and layered over discontinuous Renografin gradients ( 13 ml of 40%, 8 ml of 44%, and 5 ml of 52% Renografin, vol/vol), centrifuged at 43 000 g for 1 h at 4°C in a SW 27 rotor. The elementary body band was collected by Pasteur pipette, diluted in 0 01 M HEPES, and then centrifuged at 30 000 g for 30 min. The protein content of preparations was determined by the method of Lowry et al. 23 Control antigen was prepared in the same way from uninfected LLC-MK2 cells.
Micro ELISA plates (Dynatech M129A) were coated with 100 ,ul of elementary bodies or control antigen in carbonate-bicarbonate buffer pH 9-6 for 1 h at room temperature. The final protein concentration of elementary body or control antigen preparations was 20 ug/ml. Coated plates were washed five times with phosphate buffered saline (PBS)-Tween (Sigma Chemical, St Louis, Missouri) and used immediately. Serial twofold dilutions of human sera in PBS-Tween were made in the test plate. Each serum dilution was tested in elementary body and control antigen coated wells. A known positive and one negative serum sample were assayed on each plate. The plate was then incubated at 37°C for 1 h and washed 10 times with PBSTween. Antihuman IgA (a-chain) peroxidase labelled (Dako, Copenhagen, Denmark) diluted 1/400 in PBS-Tween was added in a volume of 100 gl per well. The plate was incubated for 1 h at 37°C, washed 10 times with PBS-Tween. Thereafter, 100 ,ul of the citric acid phosphate buffer (pH 5 6) containing 40 mg 1.2 phenylendiaminedihydrochloride (Merck, Darmstadt, West Germany) and 20 ul of 30% H202 per 100 ml buffer was added per well. The enzymatic reaction was stopped after 15 min by adding 100 ,ul of 2 N H2SO4 per well. (Fig. 1) .
Antibody titres were expressed as the reciprocal of the highest serum dilution that yielded an optical density at 492 nm > 5 standard deviations over the mean of values obtained with sera from 10 children negative by immunofluorescence for serum IgA to C trachomatis, and tested by ELISA in a separate experiment. The IgA antibody titres ranged from 8 to 512.
The titration results for all sera tested with ELISA and immunofluorescence tests are shown in Fig. 2 . Of the 182 sera tested 120 were negative and 59 were positive by both techniques. Since the half life of C trachomatis IgA was five to six days in normal subjects27 the presence of these antibodies may be a better marker for active C trachomatis infection than C trachomatis IgG antibody. Confirmation of this will require relating the presence of C trachomatis serum IgA antibody with the isolation of the agent from the fallopian tube.
The availability of a serological marker of C trachomatis infection in patients with acute salpingitis would be of considerable value and might obviate the need for invasive procedures in the diagnosis of acute salpingitis.
A clear cut association between C trachomatis specific serum IgA and active C trachomatis infection was found in men with C trachomatis positive non-gonococcal urethritis. Of these, 94-1% had C trachomatis serum IgA compared with only 20-5% of C trachomatis negative non-gonococcal urethritis patients (p < 0.0005) and 5 9% of healthy subjects (p < 0.0005). Ninety seven per cent of C trachomatis positive non-gonococcal urethritis patients also had serum IgG compared with 33*3% of C trachomatis negative non-gonococcal urethritis patients (p < 0.0005) and 23-5 % of healthy men.
In a previous study, Thero and Meurman,'4 using a radioimmunoassay technique, found serum IgA in only 53% of isolation positive as against 21% isolation negative men with urethritis. The different results obtained in the current study can be tentatively explained both by the different population examined and by the methods used. In this study specific C trachomatis IgA antibody was always found in association with serum IgG antibody: the higher the IgG titre the higher the IgA titre, the highest IgA titres being found in patients with acute salpingitis. In C trachomatis positive non-gonococcal urethritis patients serum IgA was also found in the presence of low (16-32) IgG titres.
In conclusion, the presence of serum IgA antibody to C trachomatis seems to be correlated with active C trachomatis infection, at least in patients with chlamydial non-gonococcal urethritis. Hence, IgA detection may be a useful further test in chlamydial serology. However, the possibility that C trachomatis serum IgA can be used as a marker of a current C trachomatis infection needs further investigation. The appearance and persistence of C trachomatis IgA have to be examined in prospective studies and correlated wth the development of symptomatic or asymptomatic C trachomatis infections.
